Shorewind Capital is a U.S.-focused venture capital firm backing early-stage and Series B technology and life sciences companies. It invests across AI, climate and mobility, healthtech, biotech, robotics, SaaS, semiconductors, hardware and related food and medical-device technologies. Portfolio examples include SiPhox Health, Synthesia, poolside, Fleetzero and NewLimit, making it relevant for founders building science- or technology-driven companies seeking venture backing.